Zhuhai Trinomab Pharmaceutical Co., Ltd. (SHA:688806)
25.90
+2.06 (8.64%)
At close: Aug 4, 2026
SHA:688806 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Cash & Equivalents | 475.3 | 515.37 | 559.41 | 594.72 | 758.35 |
Short-Term Investments | - | - | - | 30.81 | - |
Cash & Short-Term Investments | 475.3 | 515.37 | 559.41 | 625.53 | 758.35 |
Cash Growth | -37.33% | -7.87% | -10.57% | -17.51% | - |
Accounts Receivable | 66 | 83.14 | - | - | 16.31 |
Other Receivables | 3.1 | 3.01 | 2.38 | 1.68 | 1.61 |
Receivables | 69.09 | 86.15 | 2.38 | 1.68 | 17.92 |
Inventory | 103.48 | 95.16 | 57.53 | 25.08 | 23.18 |
Other Current Assets | 61.83 | 41.95 | 9.62 | 11.54 | 32.03 |
Total Current Assets | 709.7 | 738.63 | 628.96 | 663.82 | 831.47 |
Property, Plant & Equipment | 186.2 | 190.42 | 219.13 | 230.81 | 215.27 |
Long-Term Investments | - | - | 12.21 | 11 | - |
Other Intangible Assets | 4.95 | 5.36 | 2.86 | 3.5 | 3.61 |
Long-Term Deferred Charges | 12.65 | 15.36 | 35.36 | 64.39 | 89.13 |
Other Long-Term Assets | 20.3 | 28.72 | 34.78 | 18.41 | 11.97 |
Total Assets | 933.8 | 978.5 | 933.3 | 991.93 | 1,151 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Accounts Payable | 15.47 | 35.65 | 93.21 | 28.93 | 35.37 |
Accrued Expenses | 40.84 | 51.53 | 29.29 | 22.71 | 17.88 |
Short-Term Debt | 46.99 | 67.01 | 71.19 | 28.03 | 30.03 |
Current Portion of Long-Term Debt | 251.39 | 216.71 | 64.3 | 2.97 | 19.29 |
Current Portion of Leases | 11.3 | 11.47 | 12.65 | 9.62 | 14.01 |
Current Income Taxes Payable | - | - | - | - | 0 |
Current Unearned Revenue | 45.47 | 58.77 | 8 | 17.62 | 9.9 |
Other Current Liabilities | 15.66 | 11.65 | 6.73 | 6.73 | 7.85 |
Total Current Liabilities | 427.12 | 452.79 | 285.38 | 116.61 | 134.33 |
Long-Term Debt | 432.76 | 363.74 | 208.15 | 111.59 | 32.01 |
Long-Term Leases | 37.53 | 36.97 | 45.98 | 51.42 | 24.15 |
Long-Term Unearned Revenue | 8.92 | 9.34 | 10.74 | - | - |
Total Liabilities | 906.33 | 862.84 | 550.25 | 279.63 | 190.49 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Common Stock | 391.46 | 391.46 | 371.2 | 360 | 148.62 |
Additional Paid-In Capital | 1,170 | 1,162 | 859.5 | 685.23 | 1,896 |
Retained Earnings | -1,545 | -1,449 | -847.7 | -332.93 | -1,083 |
Comprehensive Income & Other | -0.69 | -0.49 | 0.05 | 0 | -0.02 |
Total Common Equity | 15.79 | 103.66 | 383.05 | 712.3 | 960.96 |
Minority Interest | 11.68 | 12.01 | - | - | -0 |
Shareholders' Equity | 27.47 | 115.66 | 383.05 | 712.3 | 960.96 |
Total Liabilities & Equity | 933.8 | 978.5 | 933.3 | 991.93 | 1,151 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Total Debt | 779.97 | 695.91 | 402.27 | 203.64 | 119.5 |
Net Cash (Debt) | -304.67 | -180.53 | 157.14 | 421.9 | 638.86 |
Net Cash Growth | - | - | -62.75% | -33.96% | - |
Net Cash Per Share | -0.78 | -0.47 | 0.43 | 1.34 | 3.99 |
Filing Date Shares Outstanding | 391.46 | 391.46 | 371.2 | 314.41 | 159.95 |
Total Common Shares Outstanding | 391.46 | 391.46 | 371.2 | 314.41 | 159.95 |
Working Capital | 282.59 | 285.84 | 343.58 | 547.21 | 697.14 |
Book Value Per Share | 0.04 | 0.26 | 1.03 | 2.27 | 6.01 |
Tangible Book Value | 10.84 | 98.29 | 380.18 | 708.8 | 957.36 |
Tangible Book Value Per Share | 0.03 | 0.25 | 1.02 | 2.25 | 5.99 |
Machinery | 243 | 242.09 | 236.55 | 215.04 | 205.79 |
Construction In Progress | 1.74 | 1.49 | 1.72 | 8.57 | 5.42 |